Jan 12, 2024
1:25
For every 25 shares held, investors received 1. The price per share adjusted from $0.43 to $0.02.
The split itself did not change the total investment value.
eFFECTOR Therapeutics, Inc. (EFTR) trades on the Other OTC in the Biotechnology industry.
eFFECTOR Therapeutics, Inc. company overviewThe latest split shown was on January 12, 2024. It was a 1-for-25 reverse split, so shareholders received 1 share for every 25 they held.
This history records one reverse split, on January 12, 2024.